NCT07174115View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions

Chronic Sinusitis Without Nasal Polyps

Interventions

DRUG

HTMC0658

HTMC0658 tablet

Trial Locations (1)

Unknown

RECRUITING

Luoyang First People's Hospital, Luoyang

All Listed Sponsors

lead

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

INDUSTRY

NCT07174115 - A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps | Biotech Hunter | Biotech Hunter